Identification of PRDX5 as A Target for The Treatment of Castration-Resistant Prostate Cancer

By sjmartinez • December 20, 2023

Wang R, Mi Y, Ni J, Wang Y, Ding L, Ran X, Sun Q, Tan SY, Koeffler HP, Feng N, Chen YQ. Identification of PRDX5 as A Target for The Treatment of Castration-Resistant Prostate Cancer. Adv Sci (Weinh). 2023 Dec 20:e2304939. doi: 10.1002/advs.202304939. Epub ahead of print. PMID: 38115765.

Tags: castration-resistant prostate cancer, Cedars Sinai DoM, Drug-tolerant persister, Hematology/Oncology, peroxiredoxin 5, polaprezinc, Publications, stachyose

Deep Learning with Domain Randomization in Image and Feature Spaces for Abdominal Multiorgan Segmentation on CT and MRI Scans

Shi Y, Wang L, Qureshi TA, Deng Z, Xie Y, Li D. Deep Learning with Domain Randomization in Image and Feature Spaces for Abdominal Multiorgan[...]

Accelerating CEST MRI With Deep Learning-Based Frequency Selection and Parameter Estimation

Shen C, Cheema K, Xie Y, Ruan D, Li D. Accelerating CEST MRI With Deep Learning-Based Frequency Selection and Parameter Estimation. NMR Biomed. 2025 Jul;38(7):e70068.[...]

Immune-mediated adverse events and overall survival with tremelimumab plus durvalumab and durvalumab monotherapy in unresectable hepatocellular carcinoma: HIMALAYA phase 3 randomized clinical trial

Lau G, Sangro B, Cheng AL, Kudo M, Kelley RK, Tak WY, Gasbarrini A, Reig M, Lim HY, Tougeron D, De Toni EN, Tam VC,[...]